» Articles » PMID: 12640674

Requirement of Both Mucins and Proteoglycans in Cell-cell Dissociation and Invasiveness of Colon Carcinoma HT-29 Cells

Overview
Journal Int J Cancer
Specialty Oncology
Date 2003 Mar 18
PMID 12640674
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Human colon carcinomas are characterized by an aberrant expression of mucins, which in some case leads to an abundant presence of mucus such as in mucinous and signet ring cell carcinomas. Cellular cloning of the human colon carcinoma cell line HT-29 (HT-29 STD), which is mainly composed of undifferentiated cells, yielded a highly mucin-secreting variant (HT-29 5M21). The latter cloned cells cultured on plastic display a polarized organization with an apical secretion of MUC5AC mucin (Lesuffleur et al., Int J Cancer 1998;76:383-92.). Our aim was to study these 2 cell-types as for the invasive and adhesive properties with regard to the function of E-cadherin. HT-29 STD cells were noninvasive in collagen type I, whereas HT-29 5M21 cells were invasive, and the latter behavior was connected to a loss of function of E-cadherin. Likewise, HT-29 5M21 cells were characterized by a cell-cell adhesion independent of E-cadherin, in contrast to the E-cadherin dependent cell-cell adhesion of HT-29 STD cells. Immunofluorescence of HT-29 5M21 cells cultured on collagen type I showed the disappearance of the polarized organization, with a redistribution of apical mucins to the entire cell surface. Treatment of HT-29 5M21 cells by 1-benzyl-2-acetamido-2-deoxy-alpha-D-galactopyranoside (GalNAcalpha-O-bn) or by beta-D-xyloside revealed that both mucins and proteoglycans were involved in the loss of E-cadherin function. The use of specific antibodies allowed to show that MUC5AC, MUC1 and heparan sulfate proteoglycans cooperated in the formation of a biological inhibitory complex towards the function of E-cadherin in this invasive HT-29 clone.

Citing Articles

How do intestinal probiotics restore the intestinal barrier?.

Gou H, Zhang Y, Ren L, Li Z, Zhang L Front Microbiol. 2022; 13:929346.

PMID: 35910620 PMC: 9330398. DOI: 10.3389/fmicb.2022.929346.


Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments.

Calabro M, Lazzari N, Rigotto G, Tonello M, Sommariva A Int J Mol Sci. 2020; 21(23).

PMID: 33266161 PMC: 7731245. DOI: 10.3390/ijms21239120.


Unraveling mucin domains in cancer and metastasis: when protectors become predators.

Ganguly K, Rauth S, Marimuthu S, Kumar S, Batra S Cancer Metastasis Rev. 2020; 39(3):647-659.

PMID: 32488403 PMC: 7487023. DOI: 10.1007/s10555-020-09896-5.


Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character.

Crespo A, Garcia-Suarez O, Fernandez-Vega I, Solis-Hernandez M, Garcia B, Castanon S BMC Cancer. 2018; 18(1):687.

PMID: 29940912 PMC: 6019305. DOI: 10.1186/s12885-018-4597-x.


Nano-liquid Chromatography-orbitrap MS-based Quantitative Proteomics Reveals Differences Between the Mechanisms of Action of Carnosic Acid and Carnosol in Colon Cancer Cells.

Valdes A, Garcia-Canas V, Artemenko K, Simo C, Bergquist J, Cifuentes A Mol Cell Proteomics. 2016; 16(1):8-22.

PMID: 27834734 PMC: 5217784. DOI: 10.1074/mcp.M116.061481.